Biomark Diagnostics Market Cap

Biomark Diagnostics has a market cap or net worth of €37.2 million as of March 20, 2026. Its market cap has increased by 214.86% in one year.

Market Cap

37.20M

Enterprise Value

36.85M

Revenue

57.01K

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.35

Market Cap Chart

Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 37.20M, an increase of 30.55%. That is a compound annual growth rate of 2.38%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	37.20M	14.19%
Dec 30, 2025	32.58M	228.85%
Dec 30, 2024	9.91M	-19.08%
Dec 29, 2023	12.24M	23.53%
Dec 30, 2022	9.91M	-23.89%
Dec 30, 2021	13.02M	134.71%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PEH Wertpapier AG	48.68M
Fernheizwerk Neukölln Aktiengesellschaft	45.77M
learnd SE	45.08M
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877-	44.93M
Fair Value REIT-AG	41.53M
Enapter AG	40.79M
U.C.A. Aktiengesellschaft	37.09M
SBF AG	36.69M

Market Cap Rankings